ConductScience.org, home

Paper25616355

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis.

Engels CC and 12 others. Breast Cancer Res Treat, 2015. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis. Papers, record 25616355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25616355

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis.
PubMed
Journal
Breast Cancer Res Treat
PubMed
Year
2015
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
0.97
iCite
Revised in PubMed
2026-01-28
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Engels CCC C
2Charehbili AA
3van de Velde CJC J H
4Bastiaannet EE
5Sajet AA
6Putter HH
7van Vliet EAE A
8van Vlierberghe RLR L P
9Smit VTV T H B M
10Bartlett JMJ M S
11Seynaeve CC
12Liefers GJG J
13Kuppen PJP J K

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Breast NeoplasmsMajor topic
ImmunophenotypingMajor topic
Neoplasm Recurrence, LocalMajor topic
T-Lymphocytes, RegulatoryMajor topic
Adult
Aged
Aged, 80 and over
Androstadienes
Chemotherapy, Adjuvant
Combined Modality Therapy
Female
Forkhead Transcription Factors
HLA-G Antigens
Histocompatibility Antigens Class I
Humans
Middle Aged
Postmenopause
Prognosis
Receptors, Estrogen
Tamoxifen
HLA-E Antigens

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124649219FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis.Mol Clin Oncol2013https://conductscience.org/library/papers/24649219PubMed
212407407Natural selection of tumor variants in the generation of "tumor escape" phenotypes.Nat Immunol2002https://conductscience.org/library/papers/12407407PubMed
321087898Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.Lancet Oncol2010https://conductscience.org/library/papers/21087898PubMed
419188178Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients.Clin Cancer Res2009https://conductscience.org/library/papers/19188178PubMed
520145162The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer.Clin Cancer Res2010https://conductscience.org/library/papers/20145162PubMed
621483002Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.J Clin Oncol2011https://conductscience.org/library/papers/21483002PubMed
711823860Gene expression profiling predicts clinical outcome of breast cancer.Nature2002https://conductscience.org/library/papers/11823860PubMed
822301780Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers.Mol Endocrinol2012https://conductscience.org/library/papers/22301780PubMed
915761078Global cancer statistics, 2002.CA Cancer J Clin2005https://conductscience.org/library/papers/15761078PubMed
1024213679Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?Cancer Immunol Immunother2014https://conductscience.org/library/papers/24213679PubMed
1122465232What are regulatory T cells (Treg) regulating in cancer and why?Semin Cancer Biol2012https://conductscience.org/library/papers/22465232PubMed
1217445213HLA expression and cancer--14th IHIWS immunohistochemistry quality control exercise exchange results.Tissue Antigens2007https://conductscience.org/library/papers/17445213PubMed
138175547Adenosine, an endogenous anti-inflammatory agent.J Appl Physiol (1985)1994https://conductscience.org/library/papers/8175547PubMed
1412618909Analysis of HLA-E expression in human tumors.Immunogenetics2003https://conductscience.org/library/papers/12618909PubMed
1517008531Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.Science2006https://conductscience.org/library/papers/17008531PubMed
1621717105CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes.Breast Cancer Res Treat2011https://conductscience.org/library/papers/21717105PubMed
179886828Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: role of estrogen receptor-Sp1 interactions.Endocrinology1999https://conductscience.org/library/papers/9886828PubMed
1816720680Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.J Clin Oncol2006https://conductscience.org/library/papers/16720680PubMed
1916382061A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.N Engl J Med2005https://conductscience.org/library/papers/16382061PubMed
2023280127
Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients--an immunohistochemical study of Cd8+ and Foxp3+ using double immunostaining with correlation to the pathobiological response of the patients.
Int J Biol Markers2012https://conductscience.org/library/papers/23280127PubMed

See all 37 referencesDownload CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
41732488Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer.iScience2026https://conductscience.org/library/papers/41732488PubMed
41599141Breaking Barriers: Immune Checkpoint Inhibitors in Breast Cancer.Pharmaceutics2025https://conductscience.org/library/papers/41599141PubMed
38672117Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Prognostic and Predictive Significance across Molecular Subtypes.Biomedicines2024https://conductscience.org/library/papers/38672117PubMed
38310272Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects.J Transl Med2024https://conductscience.org/library/papers/38310272PubMed
37060036Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial.Breast Cancer Res2023https://conductscience.org/library/papers/37060036PubMed
36692642The prognostic values of FOXP3+ tumor-infiltrating T cells in breast cancer: a systematic review and meta-analysis.Clin Transl Oncol2023https://conductscience.org/library/papers/36692642PubMed
36119489Association of the TGFβ gene family with microenvironmental features of gastric cancer and prediction of response to immunotherapy.Front Oncol2022https://conductscience.org/library/papers/36119489PubMed
36046791Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36046791PubMed
34361031A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome.Int J Mol Sci2021https://conductscience.org/library/papers/34361031PubMed
34276691HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges.Front Immunol2021https://conductscience.org/library/papers/34276691PubMed
34180352Infiltrating T-cell abundance combined with EMT-related gene expression as a prognostic factor of colon cancer.Bioengineered2021https://conductscience.org/library/papers/34180352PubMed
33435254Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer.Int J Mol Sci2021https://conductscience.org/library/papers/33435254PubMed
32106121Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1.Chin Med J (Engl)2020https://conductscience.org/library/papers/32106121PubMed
31829264Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy.Breast Cancer Res2019https://conductscience.org/library/papers/31829264PubMed
31391067Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes.Breast Cancer Res2019https://conductscience.org/library/papers/31391067PubMed
30319626Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges.Front Immunol2018https://conductscience.org/library/papers/30319626PubMed
30172273[Study Progression on Non-small Cell Lung Cancer with EGFR Mutation Treated by Immune Checkpoint Inhibitors].Zhongguo Fei Ai Za Zhi2018https://conductscience.org/library/papers/30172273PubMed
29983594A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease.Cancer Manag Res2018https://conductscience.org/library/papers/29983594PubMed
29780664A New Paradigm for Tissue Diagnostics: Tools and Techniques to Standardize Tissue Collection, Transport, and Fixation.Curr Pathobiol Rep2018https://conductscience.org/library/papers/29780664PubMed
29187886Prognostic value of tumor-infiltrating Foxp3+ regulatory T cells in patients with breast cancer: a meta-analysis.J Cancer2017https://conductscience.org/library/papers/29187886PubMed

See all 24 cited byDownload CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25616355

GET https://conductscience.org/api/papers/v1/25616355/references?page=2